The global dermatology drugs market was valued at around $32 billion in 2017. North America was the largest region in the dermatology drugs market in 2017, accounting for around 31% market share. The USA was the largest country in the market in 2017, accounting for over 24% market share.
Historically, the Global Dermatology Drugs Market size grew at a compound annual growth rate (CAGR) of nearly 5%. This can be attributed ... Read more
Increasing personal spending, strong pipeline of dermatological drugs, and growing awareness about skin diseases are the key factors boosting the demand for dermatology drugs globally.
On the basis of treatment, the dermatology drugs market has been categorized into topical corticosteroids, retinoids, biologics, calcineurin inhibitors, antihistamines, hormonal therapy, and others. Among these, biologics is expected to be the fastest growing category, advancing at CAGR of 9.1% during ... Read more
The dermatology drugs market consists of sales of dermatology drugs and related by entities (organizations, sole traders and partnerships) that produce dermatology drugs to treat skin diseases. This industry includes establishments that produce drugs to treat diseases such as rosacea, dermatitis, hyperhidrosis, androgenic alopecia, acne, microbial infections and other skin disorders.
The dermatology drugs market expected to reach a value of nearly $91.28 billion by 2022, ... Read more
